Netherlands
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 10.00 B
|
Dec. 31, 2023 | USD 24.98 | -2.69% |
|
Netherlands |
|
2 |
USD 1.60 B
|
Dec. 31, 2023 | USD 139.49 | 1.47% |
|
Netherlands |
|
3 |
USD 1.23 B
|
Dec. 31, 2023 | USD 45.57 | -0.94% |
|
Netherlands |
|
4 |
USD 550.34 M
|
Dec. 31, 2023 | USD 13.23 | -4.06% |
|
Netherlands |
|
5 |
USD 336.26 M
|
Dec. 31, 2023 | USD 121.51 | 5.06% |
|
Netherlands |
|
6 |
USD 166.10 M
|
Dec. 31, 2023 | USD 9.93 | 5.98% |
|
Netherlands |
|
7 |
USD 68.75 M
|
Dec. 31, 2023 | USD 2.26 | -0.44% |
|
Netherlands |
|
8 |
USD 35.59 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
9 |
USD 30.06 M
|
Dec. 31, 2023 | USD 39.01 | -3.56% |
|
Netherlands |
|
10 |
USD 21.96 M
|
Dec. 31, 2023 | USD 673.61 | 1.66% |
|
Netherlands |
|
11 |
USD 8.81 M
|
Dec. 31, 2023 | USD 23.67 | -3.70% |
|
Netherlands |
|
12 |
USD 48.08 K
|
Dec. 31, 2023 | USD 16.00 | -2.50% |
|
Netherlands |
The Pharmaceuticals company in Netherlands with the highest Total Non-Current Liabilities is Koninklijke Philips N.V. (Amsterdam Stock Exchange: PHIA.AS) at USD 10.00 B.
The Pharmaceuticals company in Netherlands with the lowest Total Non-Current Liabilities is Pharvaris N.V. (NasdaqGS: PHVS) at USD 48.08 K.
The top 10 Pharmaceuticals companies in Netherlands by Total Non-Current Liabilities are Koninklijke Philips N.V., IMCD N.V., Qiagen N.V., uniQure N.V., Redcare Pharmacy NV, Pharming Group N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V., Merus N.V. and argenx SE.
The bottom 10 Pharmaceuticals companies in Netherlands by Total Non-Current Liabilities are Pharvaris N.V., NewAmsterdam Pharma Company N.V., argenx SE, Merus N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Pharming Group N.V., Redcare Pharmacy NV, uniQure N.V. and Qiagen N.V..